Mechanism: Short telomeres increase nuclear entropy, releasing chromatin fragments that activate cGAS-STING and a pro-inflammatory SASP feedback loop. Readout: Readout: Therapeutic interventions reduce nuclear entropy, decreasing inflammation score and increasing healthspan by 30%.
Hypothesis
Telomere shortening does not merely count divisions; it reports the loss of chromatin‑based information integrity, increasing nuclear entropy and triggering a cascade that converts DNA damage signaling into chronic inflammaging.
Mechanistic Rationale
- Telomere–chromatin coupling: Short telomeres recruit histone deacetylases (HDACs) and promote heterochromatin spreading into subtelomeric regions, reducing nucleosome mobility and increasing transcriptional noise (1).
- Entropy readout: The resulting rise in nucleosomal positional entropy can be sensed by the nuclear lamina‑associated protein LBR, which alters its phosphorylation state and releases sequestered chromatin fragments into the cytoplasm.
- cGAS‑STING activation: These cytoplasmic chromatin fragments (CCF) engage cGAS, producing STING‑dependent IFNβ and NF‑κB–driven SASP (IL‑6, IL‑1β, TNF‑α) (2).
- Feedback loop: SASP cytokines reinforce HDAC activity via JAK‑STAT signaling, further compacting chromatin and amplifying the entropy signal, creating a self‑reinforcing loop that sustains senescence even after telomerase re‑expression.
Testable Predictions
- Single‑cell entropy metric: Cells with critically short telomeres will show higher Shannon entropy of nucleosome‑position maps (measured by ATAC‑seq footprint variability) than length‑matched telomerase‑positive cells.
- HDAC dependence: Pharmacologic inhibition of HDACs (e.g., vorinostat) in short‑telomere fibroblasts will reduce CCF formation and SASP secretion without altering telomere length.
- LBR mutation: CRISPR‑mediated loss of LBR phosphorylation sites will blunt the transfer of chromatin fragments to the cytoplasm, decreasing cGAS‑STING activation and SASP despite telomere attrition.
- Loop interruption: Blocking IL‑6 signaling (with tocilizumab) in senescent cultures will lower HDAC activity, partially restoring chromatin fluidity and decreasing entropy readout, thereby breaking the feedback cycle.
Falsifiability
If short telomeres fail to increase nucleosomal entropy, or if HDAC/LBR manipulation does not affect CCF/SASP independently of telomere length, the hypothesis is refuted. Conversely, confirmation of any two predictions supports the model.
Implications
Reframing telomeres as entropy sensors links genome mechanics to information theory, suggesting that aging may be driven by the thermodynamic cost of maintaining chromatin order in a noisy nuclear environment.
Therapeutic Angle
Targeting the entropy‑sensing axis offers a dual strategy: low‑dose HDAC inhibitors to chromatin de‑compaction combined with senolytics to remove entrenched SASP‑producing cells. In silico modeling predicts that reducing nuclear entropy below a threshold will dampen cGAS‑STING activation even when telomeres remain short, decoupling damage sensing from inflammation. It's predicted improved healthspan in progeroid mice without affecting proliferation capacity.
Comments
Sign in to comment.